The Executive Committee of Fagron is composed as follows:
Hans Stols (1959, the Netherlands) - Chief Executive Officer
Hans Stols is the Chief Executive Officer of Fagron. Mr. Stols has held various positions at the Rijksaccountantsdienst, ABN-AMRO Bank N.V. and Stada Arzneimittel AG. Until 2006 Mr. Stols was Chief Operational Officer and member of the board of directors of Stada Arzneimittel AG and was founding member of the board of many Stada subsidiaries. Mr. Stols also provides consulting services to many corporations, including Stada Arzneimittel AG and Goldman Sachs London (ad hoc) and has, among other things, been chairman of the European Generic Medicine Association, Vereniging Euro Specialite’s and Nederlandse Cystic Fibrosis Stichting.
Karin de Jong (1979, the Nederlands) - Chief Financial Officer
Karin de Jong is the Chief Financial Officer of Fagron. After graduating in Business Administration, Accounting & Control, Karin completed the post-graduate Register Controller degree at Erasmus University. She has been working for Fagron since 2008, where she started as Business Controller. In 2013 she was appointed Group Controller. In 2016 she was appointed CFO of Fagron.
Rafael Padilla (1978, Spain) - Area General Manager South America and Southern Europe
Rafael graduated from the University of Barcelona in Pharmaceutical Sciences and later completed the post-graduate PMD study at IESE. He started working for Fagron in 2002 as a pharmacist. In 2013 he became General Manager of Fagron South America, Fagron Italy and Iberica.
Constantijn van Rietschoten (1970, the Netherlands) - Chief Communications Officer
Constantijn has studied Politics & Public Administration at Erasmus University. He started working for Fagron in 2008 as Director Investor Relations. From 2012 till 2016 he was responsible for the Global Marketing and Innovation department of Fagron. As from February 2017 he is responsible for Corporate Communications and the activities of Fagron in Australia and South-Africa.
Rita Hoke - President of Fagron North America
Mrs. Hoke is a pharmacist and started her career at Baxter Healthcare, a leading American healthcare company, where she worked in roles of increasing responsibility across multiple functions. From 2004 until 2011, she was responsible for the hospital division in the United States for Grifols, a Spanish multinational active in healthcare and bioscience. Since 2011, she has been active as an advisor for multinationals that are or want to become active in the compounding business in the United States.